Authors
Randy Dotinga is a medical writer based in San Diego, Calif.
professor and chair, department of dermatology, Director Temple Itch Center, Temple University Health System
Ilya Petrou, MD, is a contributing writer for Dermatology Times.
Advertisement
Advertisement
Trending on Dermatology Times
1
Lutikizumab Meets Primary End Point in Phase 3 HS Trial
2
Dupilumab Associated With Lower Atopic March Risk in Pediatric Atopic Dermatitis
3
AAD, HS Foundation Issue First Joint Hidradenitis Suppurativa Guidelines
4
Tolerability and Response Criteria Guide Hedgehog Inhibitor Choice in Advanced BCC
5

